Finance

Lists
Why is CHEK down 13,45%?
Dive Deeper
CHEK:IDX
Diastika Biotekindo Tbk PT
103,00 IDR
-13,45%
(-16,00) 1D
16-окт., 16:12:39 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for CHEK...
Open
117 IDR
High
117 IDR
Low
102 IDR
Mkt. cap
423,67 млд
Avg. vol.
1,88 млн
Volume
1,21 млн
P/E ratio
11,92
52-wk high
194 IDR
52-wk low
102 IDR
EPS
9 IDR
Shares outstanding
4,11 млд
No. of employees
123
Open
117 IDR
High
117 IDR
Low
102 IDR
Mkt. cap
423,67 млд
Avg. vol.
1,88 млн
Volume
1,21 млн
P/E ratio
11,92
52-wk high
194 IDR
52-wk low
102 IDR
EPS
9 IDR
Shares outstanding
4,11 млд
No. of employees
123
News stories
From web sources and news partners
About Diastika Biotekindo Tbk PT
CEO-
Employees123
Founded1989
Headquarters-
SectorHealth care provider
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
53,43 млд
69,56 млд
37,27 млд
45,01 млд
Cost of goods sold
31,60 млд
47,95 млд
21,86 млд
25,83 млд
Cost of revenue
31,60 млд
47,95 млд
21,86 млд
25,83 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,99 млд
13,45 млд
14,30 млд
16,02 млд
Operating expense
14,93 млд
15,29 млд
14,30 млд
16,02 млд
Total operating expenses
46,54 млд
63,24 млд
36,16 млд
41,85 млд
Operating income
6,89 млд
6,32 млд
1,11 млд
3,16 млд
Other non operating income
1,84 млд
-2,11 млд
10,58 млн
124,11 млн
EBT including unusual items
8,98 млд
4,17 млд
686,59 млн
2,81 млд
EBT excluding unusual items
8,89 млд
4,26 млд
686,59 млн
2,81 млд
Income tax expense
-
4,38 млд
-
-
Effective tax rate
-
105,01%
-
-
Other operating expenses
-58,75 млн
1,84 млд
-
-
Net income
8,98 млд
-209,18 млн
686,59 млн
2,81 млд
Net profit margin
16,80%
-0,30%
1,84%
6,25%
Earnings per share
-
-
-
-
Interest and investment income
191,96 млн
1,55 млд
290,70 млн
914,01 млн
Interest expense
-29,15 млн
-
-725,65 млн
-1,38 млд
Net interest expenses
162,81 млн
1,55 млд
-434,94 млн
-467,91 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
8,79 млд
9,65 млд
5,43 млд
7,61 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору